Traditional Chinese Medicine Improves Outcomes in HFrEF Traditional Chinese Medicine Improves Outcomes in HFrEF

In the randomized trial QUEST trial, a traditional Chinese medicine called qiliqiangxin provided significant reductions in CV death and hospitalization on top of guideline-directed therapy in HFrEF.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology News Source Type: news